TrialPloS one2022

Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686].

Benjamin Rix Brooks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.